Clinical Trial Update: A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients [Phase 3]

View source ↗

Summary

A Phase 3 pediatric trial of voriconazole for serious Candida infections, including oropharyngeal candidiasis, was terminated; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Oropharyngeal Candidiasis

Drugs mentioned

• VFEND (Voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Candidiasis | Phase 3 | Status: TERMINATED | Results posted: 2015-08-17